Financial Performance - The revenue from the ongoing business, primarily the new energy vehicle segment, was RMB 134.01 million in 2022, representing a 78.71% increase from RMB 74.99 million in 2021[17]. - The sales revenue from automotive and automotive parts surged from RMB 1.75 million in 2021 to RMB 60.63 million in 2022[17]. - The total loss for the reporting period was RMB 27,663.71 million, a 50.90% reduction compared to the loss in 2021[20]. - The gross loss for the year was RMB (93,858) thousand, an improvement from RMB (170,840) thousand in the previous year[130]. - Operating loss for the year was RMB (12,141,468) thousand, compared to RMB (24,844,989) thousand in 2021, indicating a reduction in losses[130]. - The total comprehensive loss for the year was RMB (29,803,297) thousand, compared to RMB (56,581,258) thousand in 2021, showing a significant decrease[131]. - The company recorded a net loss of approximately RMB 27.66 billion for the year ended December 31, 2022[122]. - The company's accumulated losses increased from RMB 71.24 billion in 2021 to RMB 98.91 billion in 2022, reflecting a rise of approximately 38.8%[127]. Assets and Liabilities - The total liabilities as of December 31, 2022, amounted to RMB 183.87 billion, an increase of RMB 62.90 billion compared to RMB 117.66 billion in 2021 after excluding advance payments[14]. - As of December 31, 2022, the total borrowings and lease liabilities of the group amounted to RMB 41,141.43 million, a slight decrease from RMB 41,678.64 million as of December 31, 2021[29]. - The total assets decreased from RMB 143.57 billion in 2021 to RMB 115.22 billion in 2022, representing a decline of approximately 19.7%[127]. - The total current assets decreased from RMB 109.85 billion in 2021 to RMB 92.82 billion in 2022, a decline of about 15.5%[127]. - The company’s property, plant, and equipment decreased from RMB 20.99 billion in 2021 to RMB 14.54 billion in 2022, a decrease of approximately 30.7%[127]. - The company’s inventory increased from RMB 200.50 million in 2021 to RMB 521.89 million in 2022, an increase of about 160.5%[127]. - The company has outstanding overdue debts totaling approximately RMB 11.63 billion as of December 31, 2022, along with overdue commercial bills amounting to approximately RMB 18.51 billion[30]. Operational Developments - The sales of the Hengchi 5 model began in July 2022, with over 320 units delivered by the end of the reporting period[12]. - The first mass-produced model, Hengchi 5, began delivery in October 2022 after starting pre-sales in July and mass production in September[21]. - The group has shifted its focus entirely to the new energy vehicle segment, discontinuing its health management services business[12]. - The group plans to focus on the development of new energy vehicles and will continue to enhance R&D investment and product offerings[28]. - The R&D team consists of 811 personnel, focusing on major development work including intelligent networking and autonomous driving technologies, with Hengchi 5 entering mass production in September 2022[68]. Governance and Management - The board of directors includes three executive directors and three independent non-executive directors, ensuring a balanced governance structure[42]. - The company is committed to maintaining transparency with shareholders regarding board member elections and service contracts[44]. - The management team is empowered to execute daily operations and make decisions on significant business issues, with certain matters requiring board approval[80]. - The company has a structured approach to board member rotation, ensuring that one-third of directors retire annually[42]. - The company’s executive team has extensive experience, with the chairman having over 30 years in business and the president over 20 years in real estate operations[45][46]. Financial Risks and Uncertainties - There is significant uncertainty regarding the group's ability to continue as a going concern, depending on successful execution of restructuring and financing plans[140]. - The company has taken measures to improve its liquidity and financial position, although significant uncertainty remains regarding its ability to continue as a going concern[122]. - The group faces multiple financial risks, including market risk (foreign exchange and interest rate risks), credit risk, and liquidity risk, with a focus on minimizing potential adverse impacts on financial performance[200]. Research and Development - The group applied for a total of 3,512 patents in related research fields, with 2,632 patents granted as of the reporting date[12]. - The company has a strong focus on research and development, with key personnel holding advanced degrees in engineering and management from reputable institutions[50]. - The company is focusing on the development of its electric vehicle segment, with a gradual slowdown in investment in battery R&D and infrastructure construction due to financial conditions[69]. Shareholder Communication - The company provides various channels for shareholders to communicate, including annual general meetings and regular updates through its website[115]. - The company emphasizes communication with institutional investors to enhance transparency and has participated in multiple roadshows and investment meetings throughout the year[119]. Revenue Recognition and Accounting Policies - The company changed its revenue recognition policy to include additional conditions for recognizing revenue, effective from January 1, 2021[141]. - Revenue is measured at fair value of consideration received or receivable, net of discounts and returns, and is recognized when specific conditions are met[192]. - The company recognizes revenue from the sale of wellness spaces, lithium batteries, and automotive parts when control of the asset is transferred to the buyer, which can occur over time or at a specific point in time[193].

New Energy Vehicle Development - The global production and sales of new energy vehicles reached 2.661 million and 2.6 million units respectively in the first half of 2022, representing a year-on-year growth of 120%[37] - The company completed the development and verification of the Hengchi 5 model, paving the way for mass production[35] - The company has 952 research and development personnel focused on software development for the Hengchi 5 and subsequent models[40] - The company is focusing on the development and mass production of complete vehicles, while gradually slowing down investment in power battery research and development[41] - The company aims to leverage government policies and market potential to strengthen technology research and development and enhance product layout in the new energy vehicle sector[39] - The company has integrated its Hengchi APP with various charging platforms, providing smart charging services to customers[43] Sales and Marketing - The company operates 23 automotive lifestyle space projects, achieving sales of 78 units with a total sales area of 6,000 square meters[44] - The company has established a sales channel network using a direct sales and authorized agency model in key cities such as Shanghai, Guangzhou, and Beijing[42] - The company has signed strategic cooperation agreements with major automotive repair brands to expand after-sales service networks nationwide[42] Financial Performance - The group reported a significant increase in revenue, with total operating revenue rising 84.72% to RMB 1,509.83 million compared to RMB 817.35 million for the same period in 2021[52] - The group recorded an operating loss of RMB 2,213.27 million during the reporting period[55] - The group reported a net loss of approximately RMB 13.365 billion for the six months ended June 30, 2022[84] - The total loss for the period was RMB 13,364,913 thousand, compared to a loss of RMB 5,548,806 thousand in the first half of 2021, reflecting an increase in losses of approximately 141.5%[92] - The company reported a net loss attributable to shareholders of RMB 13,361,778 thousand for the six months ended June 30, 2022, compared to a loss of RMB 5,486,628 thousand in the same period of 2021, representing an increase in loss of 143.5%[192] Assets and Liabilities - The group's total liabilities as of June 30, 2022, amounted to RMB 184,466.21 million, with net liabilities (excluding advance payments) at RMB 128,538.45 million, an increase of RMB 10,879.73 million year-on-year[49] - The group's debt-to-asset ratio increased to 31.76% from 29.03% at the end of 2021[58] - The total cash and cash equivalents, along with restricted cash, amounted to RMB 2,788.27 million as of June 30, 2022[57] - The group's current liabilities amounted to approximately RMB 70.614 billion[84] - The company’s total liabilities included trade and other payables amounting to RMB 12,338,168 thousand[109] Cash Flow and Financing - The company raised approximately HKD 2.7 billion by placing 900 million shares at HKD 3.00 per share, a discount of about 15.01% from the last trading price[61] - The net proceeds from the share placement, after deducting commissions and expenses, were approximately HKD 2.635 billion, fully utilized for the R&D and production of new energy vehicles[61] - The company raised RMB 3,017,334 thousand from borrowings during the period, compared to RMB 3,739,000 thousand in the same period of 2021[98] - The group is actively negotiating with banks and financial institutions to extend existing borrowings and raise short-term and/or long-term financing to fulfill financial responsibilities due within the next twelve months[111] Employee and Operational Metrics - As of June 30, 2022, the group employed 5,292 staff, with approximately 88% holding a bachelor's degree or higher, resulting in total employee costs of RMB 937.98 million[62] - Employee benefits expenses decreased to RMB 622,935 thousand for the six months ended June 30, 2022, down 55.0% from RMB 1,391,586 thousand in the same period of 2021[184] Accounting and Compliance - The company has adopted revised accounting standards effective from January 1, 2022, which are not expected to have a significant impact on the interim financial data[105] - The independent auditor's report indicates significant uncertainties regarding the group's ability to continue as a going concern[84] - The company has not yet adopted new standards related to insurance contracts and financial statement presentation, effective January 1, 2023[105] Shareholder Information - The company’s major shareholder, Evergrande Health Industry Holdings Limited, holds 6,219,500,000 shares, representing a significant portion of the total shares[76] - The major shareholder, China Evergrande Group, holds approximately 6,347,948,000 shares, representing 58.54% of the total equity[78] Contract Liabilities and Revenue Recognition - As of June 30, 2022, the company reported a contract liability of RMB 20,090,944 thousand, indicating significant unrecognized revenue[109] - The company recognized revenue related to contract liabilities of RMB 1,354,523 thousand from health management sales for the six months ended June 30, 2022[141] Impairment and Losses - The company reported a net financial asset impairment loss of RMB (102,281) thousand for the first half of 2022, compared to RMB (51,721) thousand in the same period of 2021, reflecting an increase in impairment losses of approximately 97.5%[92] - The company incurred a significant loss of RMB 4,116,376 thousand from land exit losses during the six months ended June 30, 2022, compared to RMB 159,300 thousand in the same period of 2021[185]

Financial Performance - The company's revenue for the reporting period was RMB 2,531.22 million, a significant decrease of 83.66% from RMB 15,486.63 million in 2020, primarily due to a decline in the health management segment[19]. - The group recorded a gross loss of RMB 831.84 million in the reporting period, a significant decline from a gross profit of RMB 2,790.30 million in 2020, resulting in a gross margin drop from 18.02% in 2020 to -32.86% in 2021[20]. - The group reported an operating loss of RMB 16,902.30 million for the period, with non-operating losses totaling RMB 40,376.68 million, leading to a total loss of RMB 56,344.38 million, more than a sevenfold increase compared to 2020[23][25]. - The company reported a net loss of approximately RMB 56.34 billion for the year ended December 31, 2021[132]. - The total comprehensive loss for the year was RMB 56,581,258 thousand, compared to RMB 4,915,429 thousand in 2020[141]. - The company reported a total loss of RMB 39,338,982 thousand for the year ending December 31, 2021, compared to a loss of RMB 5,838,522 thousand for the year ending December 31, 2020, reflecting a significant increase in losses[137]. Revenue Segments - The health management segment's revenue dropped from RMB 15,267.58 million in 2020 to RMB 2,388.36 million in 2021, a decrease of 84.36%[19]. - The revenue from the new energy vehicle segment decreased from RMB 187.53 million in 2020 to RMB 72.38 million in 2021, a decline of 61.41%[19]. - The automotive living space segment achieved sales of 20,090 units, totaling 1.98 million square meters, with an average discount of 37% offered to buyers[30]. - The health management segment recorded sales of 25,373 units, with a total sales area of 2.19 million square meters, where residential properties accounted for the largest share with 19,722 units sold[31]. Assets and Liabilities - The total liabilities of the company as of December 31, 2021, amounted to RMB 182,908.36 million, with a net liability of RMB 117,658.72 million after excluding advance receipts, a decrease of RMB 14,779.67 million compared to 2020[16]. - As of December 31, 2021, the total borrowings and lease liabilities amounted to RMB 41,678.64 million, down from RMB 73,010.03 million in 2020, resulting in a debt-to-asset ratio of 29.03%[33]. - The company's total assets as of December 31, 2021, amounted to RMB 143,569,374 thousand, a decrease from RMB 150,064,740 thousand as of December 31, 2020, representing a decline of approximately 4.9%[137]. - Non-current assets were valued at RMB 33,723,634 thousand as of December 31, 2021, down from RMB 46,843,248 thousand in the previous year, indicating a decrease of about 28%[137]. Cash Flow and Financing - The cash and cash equivalents, along with restricted cash, totaled RMB 5,261.22 million as of December 31, 2021[26]. - The company raised RMB 24,364,691 thousand through private placement of ordinary shares during the financing activities[144]. - The company reported a significant increase in borrowings, with RMB 14,883,197 thousand raised compared to RMB 42,391,773 thousand in the previous year[144]. - The company has capital commitments of approximately RMB 17.069 billion for the construction of various bases and fixed asset acquisitions across China[34]. Research and Development - The company established R&D bases in Shenzhen and Shanghai to focus on the development of lithium-ion batteries and next-generation battery technologies[14]. - The company aims to create a globally recognized Chinese automotive brand through technological advancements and data integration in the new energy vehicle sector[14]. - The group has over 1,285 R&D personnel and is focusing on core product development, particularly in smart connected and autonomous driving technologies[27]. - The company is advancing its battery research with plans for the development of ternary batteries and the establishment of a pilot base for lithium iron phosphate batteries[29]. Corporate Governance - The company’s board of directors includes both executive and independent non-executive members, with changes in appointments noted[48]. - The company has established a shareholder communication policy to ensure effective dialogue with institutional investors[124]. - The board of directors held a total of 6 meetings during the year, with all members attending[94]. - The company has maintained compliance with corporate governance codes and regulations throughout the year[87]. Legal and Compliance - There are currently 11 pending litigation cases with a total claim amount of approximately RMB 1.594 billion as of December 31, 2021[35]. - The company has outstanding overdue debts totaling approximately RMB 7.336 billion and overdue commercial bills amounting to approximately RMB 11.872 billion as of December 31, 2021[35]. - The independent auditor expressed significant uncertainty regarding the company's ability to continue as a going concern due to the financial situation[133]. Market Trends - In 2021, global sales of new energy vehicles reached 6.6 million units, a year-on-year increase of 108%, with China's market continuing to lead globally[26]. - The group developed six vehicle models in 2021, including Hengchi 1, 3, 5, 6, 7, and SX41, with the first Hengchi 5 successfully rolling off the production line in December 2021[27]. Employee and Management - As of December 31, 2021, the company employed 6,286 staff, with 89% holding a bachelor's degree or higher, and total employee costs of approximately RMB 2,766.01 million[38]. - The management team includes professionals with advanced degrees in engineering and business, enhancing the company's strategic capabilities[54]. - The company reported a gender ratio of 27% female to 73% male among employees, including directors and senior management, as of December 31, 2021[99].

Financial Performance - For the year ended December 31, 2022, the company reported a total loss of RMB 56,344,378, compared to a loss of RMB 27,663,709 in 2021, representing an increase of 104% in losses year-over-year[5]. - The operating loss for the year was RMB 24,844,989, which is a significant increase from RMB 12,141,468 in the previous year, indicating a worsening operational performance[5]. - The company recorded a net financial cost of RMB 1,788,377 for 2022, compared to RMB 1,222,810 in 2021, reflecting a 46% increase in financial expenses[5]. - The company reported a basic loss per share of RMB 585.319 for the year ended December 31, 2022, compared to RMB 255.080 in 2021, showing a decline in shareholder value[10]. - The company experienced a net impairment loss of RMB 11,399,078 on property, plant, and equipment, which is an increase from RMB 8,251,044 in 2021, highlighting challenges in asset valuation[5]. - The company reported a net loss attributable to shareholders of RMB 14,849,590,000 from continuing operations in 2022, a decrease from RMB 27,346,778,000 in 2021, indicating an improvement of approximately 45%[24]. - The basic loss per share from continuing operations was RMB (136.941) in 2022, compared to RMB (284.438) in 2021, reflecting a reduction of about 52%[24]. - The group reported a loss of RMB 27.664 billion for the year ended December 31, 2022, compared to a loss of RMB 56.344 billion in 2021[18]. - Cumulative losses reached RMB 98.906 billion as of December 31, 2022, up from RMB 71.241 billion in 2021[18]. - The group recorded a total loss of RMB 27,663.71 million for the reporting period, a 50.90% reduction compared to the loss in 2021[50]. Assets and Liabilities - The total assets of the company as of December 31, 2022, were RMB 115,221,255, a decrease from RMB 143,569,374 in 2021, indicating a reduction in asset base[14]. - The total liabilities of the company as of December 31, 2022, were RMB 183,872,117, slightly up from RMB 182,908,356 in 2021, indicating a stable liability position despite increased losses[14]. - The company’s equity attributable to owners decreased to RMB (39,291,901) as of December 31, 2022, from RMB (68,600,774) in 2021, reflecting a deterioration in financial health[14]. - Total liabilities for 2022 amounted to RMB 183,872.12 million, with net liabilities (excluding advance payments) of RMB 180,558.47 million, an increase of RMB 62,899.75 million from RMB 117,658.72 million in 2021[42]. - As of December 31, 2022, the group's borrowings were RMB 25,985.17 million, down RMB 14,679.74 million from RMB 40,664.91 million in 2021, with an average interest rate of 7.65%[43]. - The group's debt-to-asset ratio improved to 23.09% as of December 31, 2022, down from 29.03% a year earlier[57]. Cash Flow and Liquidity - Cash and cash equivalents stood at RMB 220 million as of December 31, 2022, a significant decrease from RMB 2.453 billion in 2021[18]. - The company's cash and cash equivalents were only RMB 219,941,000 as of December 31, 2022, raising concerns about liquidity and the ability to meet financial obligations[31]. - The group anticipates sufficient operating cash flow to meet its financial obligations for the next 12 months[20]. - The group has significant uncertainty regarding its ability to continue as a going concern, depending on successful execution of its restructuring and financing plans[20]. Operational Strategy and Restructuring - The company has not provided specific guidance for future performance or new product developments in the available documents, indicating a potential focus on restructuring and recovery strategies[5]. - The group aims to control operational and administrative costs through various measures, including optimizing production and human resources[19]. - The group has taken steps to improve its financial situation, including a business and operational restructuring plan[20]. - The group is actively negotiating with banks and financial institutions to secure financing for existing debts maturing within the next 12 months[19]. - The group is focusing on the new energy vehicle sector, having decided to gradually eliminate its health management services business[38]. - The group aims to improve manufacturing capabilities at its Tianjin base and enhance its quality system to meet planned production capacity[56]. - The group plans to enhance R&D investment to strengthen its technological foundation and focus on developing competitive new vehicle models[56]. Sales and Marketing - The group generated revenue of RMB 2.456 billion from health management and related services, with RMB 2.388 billion from wellness space sales[21]. - The annual sales volume of health management services decreased from approximately 19,000 units in 2021 to below 1,000 units in the reporting period, with total sales area dropping from about 2.2 million square meters to below 156,000 square meters[39]. - The group established 60 sales outlets in 33 key cities, utilizing a direct sales and authorized dealership model for Hengchi vehicles[54]. - The group aims to expand its marketing efforts by establishing experience centers, sales centers, and after-sales service centers[56]. Audit and Compliance - The independent auditor's report expressed a disclaimer of opinion due to significant uncertainties regarding the company's ability to continue as a going concern, with a net loss of approximately RMB 27,663,709,000 for the year ended December 31, 2022[31]. - The independent auditor noted a lack of sufficient appropriate audit evidence regarding the appropriateness of the going concern assumption, which could significantly impact the financial statements[32]. - The independent auditor confirmed that the company does not have significant off-balance sheet transactions or liabilities[35]. - The independent auditor has not expressed an opinion on the company's ability to continue as a going concern due to significant uncertainties[36]. Future Outlook - The group has not declared any dividends for the year ending December 31, 2022, consistent with the previous year[60]. - Forward-looking statements in the announcement are not guaranteed to be achieved or accurate, and shareholders or potential investors should exercise caution[65]. - Trading of the company's shares has been suspended since April 1, 2022, and will continue until further notice[66].

Financial Performance - The company reported a net loss of RMB 13,364,913 thousand for the six months ended June 30, 2022, compared to a net loss of RMB 5,548,806 thousand for the same period in 2021, representing an increase in loss of approximately 141%[4]. - The operating loss for the first half of 2022 was RMB 9,108,150 thousand, compared to an operating loss of RMB 4,672,086 thousand in the first half of 2021, reflecting a deterioration of about 95.5%[4]. - The company reported a gross loss of RMB 229,574 thousand for the first half of 2022, compared to a gross profit of RMB 556,884 thousand in the same period of 2021[3]. - The basic and diluted loss per share for the first half of 2022 was RMB 123.221, compared to RMB 58.810 for the same period in 2021, indicating an increase of approximately 109.5%[5]. - The group reported a loss of RMB 13.4 billion for the six months ended June 30, 2022[15]. - Cumulative losses and net current liabilities as of June 30, 2022, were RMB 84.6 billion and RMB 70.6 billion, respectively[15]. - The group reported income tax expenses of RMB 1,537,200 thousand for the six months ended June 30, 2022, compared to RMB 118,575 thousand in the previous year, showing a substantial increase in tax liabilities[20]. - The basic loss per share for the six months ended June 30, 2022, was RMB (123.221), compared to RMB (58.810) for the same period in 2021, indicating a significant decline in performance[27]. Revenue and Growth - Total revenue for the six months ended June 30, 2022, was RMB 1,509,833 thousand, up from RMB 817,351 thousand in the same period of 2021, indicating an increase of approximately 84.5%[3]. - Revenue from health management, including wellness space sales, reached RMB 1,485,727 thousand, significantly up from RMB 780,367 thousand in the previous year, indicating a growth of about 90.1%[18]. - The revenue from the new energy vehicle segment decreased by 34.81% to RMB 24.11 million, primarily due to the ongoing upgrade of new battery products and the clearance of existing battery inventory[41]. - The group's revenue for the six months ended June 30, 2022, was RMB 1,509.83 million, representing an increase of 84.72% compared to RMB 817.35 million for the same period in 2021[40]. - The revenue from the health management segment increased by 90.39% to RMB 1,485.73 million, driven by sales from wellness space projects rising from RMB 759.30 million to RMB 1,377.89 million[40]. Assets and Liabilities - The company's total assets decreased to RMB 130,846,805 thousand as of June 30, 2022, from RMB 143,569,374 thousand as of December 31, 2021, a decline of approximately 8.9%[7]. - The total liabilities increased to RMB 184,466,206 thousand as of June 30, 2022, from RMB 182,908,356 thousand as of December 31, 2021, an increase of approximately 0.8%[7]. - The company’s cash and cash equivalents decreased to RMB 1,609,415 thousand as of June 30, 2022, from RMB 2,452,523 thousand as of December 31, 2021, a decline of about 34.3%[6]. - The group’s total liabilities as of June 30, 2022, amounted to RMB 184,466.21 million, with net liabilities (excluding advance payments) increasing by RMB 10,879.73 million from RMB 117,658.72 million as of December 31, 2021[37]. - As of June 30, 2022, the group faced overdue debts totaling approximately RMB 8.769 billion and overdue commercial bills of about RMB 17.936 billion[52]. Operational and Financial Strategies - The group is actively negotiating with banks and financial institutions to extend existing loans and bonds maturing within twelve months after June 30, 2022, as part of its financing plan[16]. - The group has implemented operational restructuring plans to control operational and administrative costs, including optimizing production and human resources[16]. - The group is focusing on generating operational cash flow and obtaining additional financing sources to meet existing financial obligations and future capital expenditures[16]. - The group has significant uncertainties regarding its ability to continue as a going concern, dependent on successful execution of its restructuring and financing plans[17]. - The company has taken various measures to improve liquidity and financial condition, including a debt resolution plan, although the effectiveness of these measures remains uncertain[32]. Corporate Governance and Compliance - The company did not recommend the payment of an interim dividend for the six months ended June 30, 2022, compared to no dividend for the same period in 2021[55]. - The group’s interim financial information for the six months ended June 30, 2022, was reviewed by the audit committee, which consists of three independent non-executive directors[56]. - The company has complied with all provisions of the corporate governance code during the reporting period[57]. - The company has submitted information regarding the resumption of trading to the stock exchange and will provide further updates in due course[61]. - The company has not held an annual general meeting since June 18, 2021, and plans to hold one at an appropriate time[57].

Financial Performance - The total revenue for the year ended December 31, 2021, was RMB 2,531,219 thousand, a decrease from RMB 15,486,625 thousand in 2020, representing a decline of approximately 83.7%[2] - The net loss for the year was RMB 56,344,378 thousand, compared to a net loss of RMB 7,664,907 thousand in 2020, indicating an increase in losses of about 635.5%[3] - The gross loss for the reporting period was RMB 831.84 million, compared to a gross profit of RMB 2,790.30 million in 2020, resulting in a gross margin drop from 18.02% to -32.86%[43] - The company recorded an operating loss of RMB 16,902.30 million for the reporting period[44] - Non-operating losses totaled RMB 40,376.68 million, leading to a total loss of RMB 56,344.38 million for the reporting period, more than seven times the loss in 2020[45] - The company reported a net loss attributable to shareholders of RMB 7,394,075,000 for 2021, compared to a loss of RMB 7,394,075,000 in 2020, resulting in a basic loss per share of RMB (585.319) for 2021, compared to RMB (85.103) in 2020[21] Assets and Liabilities - The total assets as of December 31, 2021, amounted to RMB 143,569,374 thousand, down from RMB 150,064,740 thousand in 2020, reflecting a decrease of approximately 4.3%[5] - The company reported a significant increase in total liabilities, which rose to RMB 182,908,356 thousand in 2021 from RMB 155,903,262 thousand in 2020, an increase of about 17.3%[6] - The company’s equity attributable to owners was negative at RMB (39,291,901) thousand in 2021, compared to RMB (6,050,656) thousand in 2020, indicating a worsening financial position[6] - The total liabilities reported for 2021 amounted to RMB 182,908.36 million, with a net liability of RMB 117,658.72 million after excluding advance receipts, representing a decrease of RMB 14,779.67 million compared to 2020[39] - The asset-liability ratio as of December 31, 2021, was 29.03%, down from 48.65% as of December 31, 2020[54] Cash Flow and Liquidity - The company’s cash and cash equivalents decreased to RMB 2,808,700 thousand in 2021 from RMB 3,668,420 thousand in 2020, a decline of approximately 23.4%[5] - Cash and cash equivalents stood at RMB 2.453 billion as of December 31, 2021, a significant decrease from RMB 10.476 billion in 2020[10] - Cash and cash equivalents were reported at RMB 2,452,523,000 as of December 31, 2021, against current liabilities of RMB 57,251,098,000, indicating liquidity challenges[28] - The company has taken measures to improve its liquidity and financial position, although the effectiveness of these measures remains uncertain[28] - The independent auditor's report expressed a disclaimer of opinion due to the inability to obtain sufficient appropriate audit evidence regarding the company's ability to continue as a going concern[27] Revenue Segments - Revenue from health management services decreased to RMB 2.388 billion in 2021 from RMB 15.268 billion in 2020[18] - Revenue from lithium battery sales was RMB 9.919 million in 2021, down from RMB 81.620 million in 2020[18] - The company has changed its revenue recognition policy to include additional conditions for recognizing income, effective from January 1, 2021[13] Operational Restructuring - The group plans to implement operational restructuring measures, including cost control and capital expenditure management, to alleviate liquidity pressure[10] - The health management segment was planned to be divested in August 2021 to concentrate resources on the new energy vehicle segment[38] - The company is focused on building a comprehensive health service platform, although it plans to shift its strategic focus away from this segment[38] Research and Development - The new energy vehicle segment has made significant progress, launching an intelligent vehicle operating system and an automatic parking system during the reporting period[37] - The company applied for a total of 3,227 patents in the new energy vehicle segment, with 1,793 patents granted, covering key areas such as electric chassis structure and battery management systems[37] - The company established R&D bases in Shenzhen and Shanghai, focusing on the development of lithium-ion batteries and next-generation battery technologies[37] Related Party Transactions - The company has engaged in related party transactions for real estate marketing services from January 1, 2021, to December 31, 2022[61] - The total service fee for real estate marketing services amounted to approximately RMB 454,207 thousand for the year ended December 31, 2021, and approximately RMB 6,928 thousand for the year ended December 31, 2022[63] - The company recognizes the benefits of engaging China Evergrande Group for real estate marketing services due to its extensive experience and resources[69] Compliance and Governance - The company is focused on ensuring compliance with regulatory requirements[83] - The company has committed to strengthening internal controls to prevent future non-compliance incidents[80] - The company will provide regular training to employees on regulatory and legal topics, including compliance with related party transaction regulations[81] Trading Status - The company's shares have been suspended from trading since April 1, 2022, until further notice[83] - The company has submitted information regarding the resumption of trading to the Stock Exchange[83]

Automotive Industry Performance - In the first half of 2021, China's automobile production and sales reached 12.569 million and 12.891 million units, respectively, representing year-on-year growth of 24.2% and 25.6%[14] - New energy vehicle (NEV) production and sales reached 1.215 million and 1.206 million units, respectively, with a year-on-year increase of 100%[14] - The penetration rate of NEVs increased from 5.4% at the beginning of the year to 9.4% in the first half, exceeding 12% in June 2021[14] - The global economic recovery and favorable policies have positively impacted the automotive industry, driving growth in NEV sales[14] Company Development and Strategy - The company has developed 14 vehicle models, with 9 already launched, and aims to expand its product matrix to meet diverse market demands[13] - The company launched the H-SMART OS intelligent network system in March 2021, developed in collaboration with Tencent and Baidu, featuring advanced smart technologies[15] - The company plans to enhance its R&D capabilities and strengthen its competitive edge in both software and hardware aspects of its products[14] - The company aims to leverage opportunities from the automotive industry's transformation to develop unique and competitive NEV products[14] Health Management Services - The company has established 30 "Evergrande Health Valley" locations nationwide, focusing on comprehensive health services[13] - The company is committed to integrating health management, medical care, rehabilitation, and insurance services into its business model[13] - The "Hengda Health Valley" service has served 450,000 members and clients nationwide, with a cumulative service of 1.73 million visits as of June 30, 2021[19] - The company has established a multi-level health management model, integrating home care services and active elderly apartments to provide diverse elderly care solutions[20] Financial Performance - The group's revenue for the six months ended June 30, 2021, was RMB 6,923.24 million, a 53.5% increase compared to RMB 4,510.32 million in the same period of 2020[28] - The health management segment's revenue increased from RMB 4,446.01 million in 2020 to RMB 6,865.19 million in the reporting period, representing a growth of 54.4%[28] - The revenue from the new energy vehicle segment decreased by 30.22%, from RMB 53.00 million in 2020 to RMB 36.98 million in the reporting period, primarily due to reduced battery sales[28] - The group's gross profit for the reporting period was RMB 247.28 million, down 80.41% from RMB 1,262.35 million in 2020, with the gross margin dropping from 27.99% to 3.57%[28] Losses and Financial Challenges - The net loss for the reporting period was RMB 4,821.63 million, an increase of 96.25% compared to a loss of RMB 2,456.91 million in 2020, mainly due to reduced gross profit from health management[29] - The group is facing liquidity challenges, with delays in payments to suppliers and contractors, potentially impacting project timelines and cash flow[35] - If the company fails to secure necessary financing or implement its measures, liquidity issues may worsen, leading to loan defaults and significant adverse impacts[35] Research and Development - The company has applied for a total of 3,566 patents globally, with 1,827 patents granted, covering key areas such as electric vehicle chassis, battery management systems, and autonomous driving technologies[16] - The company has developed core technologies in the new energy vehicle industry chain, focusing on self-developed power battery technology and powertrain technology[18] - The company has multiple research and testing laboratories for battery materials, electrolyte development, and thermal management, enhancing its technological capabilities[18] Shareholder and Equity Information - As of June 30, 2021, Liu Yongzhuo holds 21,653,500 shares, representing 0.22% of the company's equity[39] - China Evergrande Group is the intermediate holding company of the company, holding 6,347,948,000 shares, which accounts for 64.98% of the total[45] - The company raised approximately HKD 26 billion from the issuance of 952,383,000 shares at a subscription price of HKD 27.30 per share[48] Cash Flow and Financing - The company raised RMB 21,803,012 thousand through private placement of ordinary shares during the reporting period[55] - The company experienced a significant increase in financing cash flow, with net cash from financing activities amounting to RMB 549,667 thousand for the first half of 2021[58] - The company is actively pursuing potential investors and asset sales to alleviate liquidity problems and reduce debt[35] Market and Economic Conditions - The company anticipates a gradual recovery in business transaction volume as COVID-19 restrictions ease in mainland China[60] - The group faces multiple financial risks, including market risk (foreign exchange and interest rate risks), credit risk, and liquidity risk, with a focus on minimizing potential adverse impacts on financial performance[67] Operational and Asset Management - The company has established manufacturing bases in Tianjin, Shanghai, and Guangzhou, and has commenced trial production of new vehicle models[17] - The company is building experience centers, sales centers, and after-sales service centers in major cities to create an online and offline transaction ecosystem[17] - The company reported a total non-current asset value of RMB 53,101,860 thousand as of June 30, 2021, compared to RMB 46,534,879 thousand at the end of 2020, reflecting an increase of approximately 14.5%[84]

Revenue and Financial Performance - The company's revenue for 2020 was RMB 15,486.63 million, a 174.8% increase from RMB 5,635.56 million in 2019[13]. - The health management segment's revenue surged from RMB 4,948.47 million in 2019 to RMB 15,268.13 million in 2020, representing a growth of 208.54%[13]. - Revenue from the new energy vehicle segment decreased by 71.61%, from RMB 660.50 million in 2019 to RMB 187.53 million in 2020, primarily due to reduced battery sales[13]. - The group's gross profit for the year was RMB 2,694.82 million, an increase of 42.80% compared to RMB 1,887.12 million in 2019, while the gross margin decreased from 33.49% in 2019 to 17.40% this year[14]. - Other income net increased from RMB 33.48 million in 2019 to RMB 214.64 million this year, primarily due to foreign exchange gains of RMB 156.94 million recorded this year, compared to a loss of RMB 34.30 million last year[14]. - Sales and marketing expenses rose from RMB 868.18 million in 2019 to RMB 2,237.85 million this year, an increase of 157.76%, mainly due to the increase in the number of new listings for the health valley project[16]. - Administrative expenses increased from RMB 3,155.62 million in 2019 to RMB 5,114.52 million this year, a rise of 62.08%, primarily due to significant R&D investments in the new energy vehicle industry[16]. - The group recorded a loss of RMB 7,664.91 million this year, widening by 54.93% from a loss of RMB 4,947.48 million in 2019, mainly due to reduced gross profit in the health business and increased marketing, interest, and R&D expenses in the new energy vehicle sector[16]. Strategic Goals and Market Position - The company aims to achieve an annual production and sales volume of over 1 million vehicles by 2025 and over 5 million vehicles by 2035[8]. - The company plans to enhance its product line by introducing more vehicle models to support the advancement of smart manufacturing in China[11]. - The new energy vehicle segment anticipates that by 2025, new energy vehicle sales will reach approximately 20% of total new car sales in China, up from the current 5%[37]. - The group aims to integrate global top resources and deepen cooperation with strategic partners to enhance its full industry chain layout[19]. Research and Development - The group plans to enhance R&D capabilities and innovation, focusing on key technologies in electric vehicles, including battery systems and autonomous driving technologies[24][25]. - The group established R&D bases in Shenzhen, Shanghai, and Osaka, Japan, with over 800 core researchers focusing on lithium-ion batteries and next-generation battery technologies[24]. - The company has established a global R&D team of over 3,500 personnel, focusing on core technologies such as lithium-ion batteries and solid-state batteries, with over 800 core researchers in battery technology[116]. - The company plans to mass-produce its high-performance battery systems in the second half of 2021, which include solutions for EV, PHEV, HEV, and energy storage applications[116]. Health Management Initiatives - The company has established 29 locations for its "Evergrande Health Valley" initiative during the reporting period[12]. - The "Evergrande Health Valley" aims to create a comprehensive health management model, integrating medical insurance, prevention, and wellness services[30]. - The company has opened 18 health and wellness experience centers across various cities, with 15 projects in trial operation and several others officially launched[124]. - The company has implemented a comprehensive health insurance system, providing high coverage for all age groups and establishing green service channels with top hospitals[126]. - The Sanya Evergrande Hospital is under construction, aiming to integrate medical, preventive, and rehabilitation services[36]. Corporate Governance and Management - The company emphasizes caution regarding forward-looking statements and advises shareholders to consult professional advisors when trading its securities[58]. - The board of directors includes several experienced individuals, with the chairman having over 28 years of business experience[74]. - The company has maintained compliance with corporate governance standards, ensuring a separation of roles between the chairman and CEO[135]. - The audit committee is responsible for reviewing the effectiveness of the internal control system and the accuracy of financial reports[146]. - The company has a dedicated investor relations department to handle shareholder inquiries and enhance engagement[184]. Financial Position and Shareholder Information - As of December 31, 2020, the group's total borrowings amounted to RMB 73,010 million, an increase from RMB 62,824 million in 2019[50]. - The group's asset-liability ratio as of December 31, 2020, was 48.65%, down from 67.26% in 2019[50]. - The company raised approximately HKD 3,999.54 million through a share placement at HKD 22.65 per share, representing a discount of about 19.96% from the last trading price[51]. - The net proceeds from the share placement were fully allocated to the development of automotive technology and construction of production bases[52]. - The company does not recommend the distribution of dividends for the current fiscal year[62]. Risk Management - The board is responsible for risk management and internal control systems, ensuring they are effective in achieving strategic objectives[159]. - The risk management framework has been enhanced, with clear roles and responsibilities established for the board and audit committee in overseeing risk management[160]. - The group conducted a comprehensive review of the risk management system, confirming its effectiveness and adequacy in addressing significant risks across its major business segments[169]. Market Trends and Industry Insights - In 2020, the domestic automobile market saw a cumulative sales volume of 25.31 million vehicles, a year-on-year decline of 1.9%, while the new energy vehicle market achieved production and sales of 1.36 million units, with production growth of 7.5% and sales growth of 10.9%[17]. - The company has extended the financial subsidy policy for promoting new energy vehicles until the end of 2022, supporting the industry's healthy development[112].

Automotive Production and Sales - In the first half of 2020, the total production and sales volume of automobiles in China was 10.112 million and 10.257 million units, respectively, representing a year-on-year decline of 16.8% and 16.9%[14]. - The production and sales volume of new energy vehicles in China during the same period were 397,000 and 393,000 units, showing a year-on-year decrease of 36.5% and 37.4%[14]. - In April, the national automobile sales reached 2.07 million units, with new energy vehicles (NEVs) sales of 72,000 units, showing a recovery trend[21]. - The company plans to produce six models of the Hengchi brand, with trial production expected in the first half of next year and mass production targeted for the second half[22]. - The company has launched six new electric vehicle models, including the Hengchi 1, a pure electric luxury D-class sedan, and Hengchi 2, a pure electric sports luxury B-class car, receiving positive market feedback[15]. New Energy Vehicle Development - The company launched six new models of its electric vehicles on August 3, 2020, covering all vehicle categories from A to D, including sedans, SUVs, and MPVs[12]. - The company has established a global research institute for new energy vehicles and has multiple high-end manufacturing bases in Sweden and China, aiming to become the largest and strongest new energy vehicle group in the world within 3-5 years[12]. - The company aims to innovate and apply new energy vehicle technologies while expanding its product line to enhance its manufacturing capabilities[12]. - The company is committed to maintaining world-leading core technologies and product quality in the new energy vehicle sector[12]. - The company has expanded its R&D team for power battery technology, achieving breakthroughs in key technology areas and establishing multiple production bases in Jiangsu and Liaoning[16]. Health Management Services - The company is actively promoting the "Healthy China" national strategy, with 28 locations of its health management service "Evergrande Health Valley" established during the reporting period[13]. - The "Evergrande Health Valley" has opened 13 health management experience centers across various cities, promoting a comprehensive health service standard[17]. - The company has integrated various health resources, including partnerships with renowned hospitals, to enhance its healthcare service levels[13]. - The company has established a high-precision health management mechanism, integrating international standards and creating a health membership data cloud platform[17]. - The company is integrating high-quality health management resources to enhance its health service capabilities and aims to become a leading brand in professional health management services in China[24]. Financial Performance - The group's revenue for the reporting period was RMB 4,510.32 million, an increase of 70.30% compared to RMB 2,648.40 million in the same period of 2019[28]. - Revenue from the health management segment rose significantly to RMB 4,446.01 million, an increase of 88.80% from RMB 2,354.88 million in 2019[28]. - Gross profit for the group was RMB 1,262.35 million, up 106.59% from RMB 611.04 million in 2019, with a gross margin increase from 23.07% to 27.99%[28]. - The group recorded a net loss of RMB 2,456.91 million, widening 23.82% from a loss of RMB 1,984.19 million in the same period of 2019[29]. - The company reported a total loss of RMB 5,697,480 thousand for the period, compared to a loss of RMB 1,295,567 thousand in the previous year[52]. Debt and Liabilities - Total borrowings and lease liabilities amounted to RMB 74,823 million as of June 30, 2020, compared to RMB 62,824 million at the end of 2019[30]. - The group's debt-to-asset ratio improved to 60.49% from 67.26% at the end of 2019[30]. - The company’s borrowings increased to RMB 54,963,784 thousand as of June 30, 2020, compared to RMB 47,214,338 thousand as of December 31, 2019, reflecting an increase of approximately 16%[53]. - Total liabilities rose to RMB 129,388,106 thousand as of June 30, 2020, compared to RMB 94,704,015 thousand as of December 31, 2019, reflecting an increase of approximately 37%[53]. - The company’s total equity decreased to RMB (7,466,957) thousand as of June 30, 2020, from RMB (7,500,436) thousand as of December 31, 2019[52]. Corporate Governance and Changes - The company changed its name to China Evergrande New Energy Vehicle Group Limited on August 20, 2020, reflecting its business development[35]. - The stock trading name was changed from "EVERG HEALTH" to "EVERG VEHICLE" effective September 1, 2020[36]. - The company’s independent auditor reviewed the financial information for the six months ended June 30, 2020, in accordance with the relevant auditing standards[40]. - The board of directors includes three independent non-executive directors, ensuring corporate governance[42]. - The company did not engage in any significant acquisitions or disposals during the reporting period[32]. Cash Flow and Investments - The net cash flow from operating activities for the six months ended June 30, 2020, was RMB (7,209,847) thousand, compared to RMB (4,454,052) thousand for the same period in 2019, representing an increase of approximately 62.2%[60]. - Cash used in investment activities amounted to RMB (4,104,511) thousand for the first half of 2020, a decrease of approximately 60.5% from RMB (10,380,054) thousand in the same period of 2019[60]. - The total cash and cash equivalents at the end of the period was RMB 10,372,252 thousand, down from RMB 16,828,869 thousand at the end of the previous year, reflecting a decrease of approximately 38.5%[60]. - The company reported a significant increase in interest payments, totaling RMB (1,779,357) thousand for the first half of 2020, compared to RMB (709,000) thousand in the same period of 2019, representing an increase of approximately 150.7%[60]. - The company incurred RMB (2,352,290) thousand in intangible asset purchases during the first half of 2020, a substantial increase from RMB (112,613) thousand in the same period of 2019[60]. Related Party Transactions - The group has engaged in significant transactions with related parties, including interest income from joint ventures amounting to RMB 139,594,000, up from RMB 66,177,000, which is an increase of 110.5%[128]. - The group’s ultimate controlling party is Dr. Xu Jiayin, who holds a 74.99% stake in the company[124]. - As of June 30, 2020, accounts receivable from related parties totaled RMB 88,576,000, a significant decrease from RMB 1,266,503,000 as of December 31, 2019, representing a decline of approximately 93%[130]. - Total liabilities to related parties increased to RMB 4,951,506,000 from RMB 3,312,231,000, reflecting an increase of about 49%[130]. - Interest payable to related parties rose to RMB 3,639,737,000 from RMB 2,221,864,000, marking an increase of about 64%[130].

Financial Performance - The company's revenue for the year 2019 was RMB 5,635.56 million, an increase of 79.88% compared to RMB 3,133.02 million in 2018[15]. - Gross profit for the year was RMB 1,887.12 million, up 64.78% from RMB 1,145.27 million in 2018, with a gross margin decrease from 36.55% to 33.49%[15]. - The company recorded a loss of RMB 4,947.48 million in 2019, compared to a loss of RMB 1,428.38 million in the same period of 2018, with losses attributable to shareholders amounting to RMB 4,426.31 million[16]. - The company reported a total revenue of approximately 4 billion HKD for the year 2019, reflecting a year-on-year increase of 15%[62]. - The company reported a 5% increase in gross margin, reaching 40% for the fiscal year 2019[62]. - The company reported a total comprehensive loss for the year was RMB 5,467,463 thousand, compared to RMB 1,494,709 thousand in 2018, showing an increase in total comprehensive loss[173]. - The company’s total liabilities reached RMB 94,704,015 thousand in 2019, up from RMB 22,845,578 thousand in 2018, a rise of about 314%[168]. - The company’s cash and cash equivalents increased to RMB 9,857,780 thousand in 2019 from RMB 1,570,014 thousand in 2018, representing a growth of approximately 528%[166]. Revenue Segments - Revenue from the health management segment increased from RMB 3,124.42 million in 2018 to RMB 4,948.47 million in 2019, representing a growth of 58.38%[15]. - The electric vehicle segment generated revenue of RMB 660.50 million, primarily from lithium battery sales[15]. - The company aims to enhance national health levels through a comprehensive health membership mechanism and multi-tiered medical services[12]. - The company is actively pursuing the development of a full industrial chain in the electric vehicle sector, focusing on core technologies and high-quality products[13]. Expenses and Liabilities - Selling and distribution expenses rose to RMB 868.18 million, an increase of 226.46% from RMB 265.94 million in 2018, due to the expansion of the "Evergrande Health Valley" projects from 12 to 23[15]. - Administrative expenses surged to RMB 3,155.62 million, an increase of 842.14% from RMB 334.94 million in 2018, driven by the rapid development of the electric vehicle business[15]. - Financial expenses increased significantly from RMB 471.34 million in 2018 to RMB 2,224.43 million, primarily due to increased interest expenses from shareholder loans[15]. - The company's non-current liabilities rose to RMB 51,580,322 thousand in 2019, compared to RMB 11,293,732 thousand in 2018, an increase of about 358%[168]. Health Management Initiatives - "Evergrande Health Valley" was successfully established in 23 locations nationwide during the year[12]. - The "Health Valley" initiative aims to create a comprehensive health service standard and integrate medical insurance with preventive care, medical treatment, and health management[18]. - The company has partnered with international medical institutions to develop a high-end medical service system, including the establishment of the Boao Evergrande International Hospital[22]. - The company has introduced a high-coverage health insurance system tailored for all age groups, providing specialized insurance for seniors under 100 years old[19]. - The company has launched a membership platform for its health management services, planning to develop 70 wellness destinations for its members over the next three years[31]. Electric Vehicle Development - The electric vehicle division has implemented multiple investments and strategic partnerships to integrate top global R&D and manufacturing resources[23]. - The company has established strategic partnerships with leading global automotive engineering firms such as FEV, EDAG, AVL, and MAGNA to develop 14 new vehicle models based on the advanced 3.0 chassis architecture, ensuring independent intellectual property rights[29]. - The company holds a 79.86% stake in Shanghai Kaineng New Energy Co., a leading player in the ternary soft-pack battery industry, and plans to expand production capacity in Jiangsu and Liaoning to meet growing market demand[27]. - The company has set up ten vehicle production bases in China, Sweden, and along the Belt and Road Initiative, with an initial planned production capacity exceeding 1 million units[26]. - The company has successfully acquired world-class intellectual property rights for the 3.0 chassis architecture from BENTELER and FEV, marking a significant advancement in its new energy vehicle business[29]. Strategic Partnerships and Collaborations - The company has formed joint ventures with Koenigsegg and other international firms to develop advanced powertrain technologies, including a limited production of 300 units of the Gemera supercar[25]. - The group aims to establish multiple super factories with an annual capacity of 60GWh within 10 years, covering various battery technologies and recycling[37]. - The company is closely monitoring the impact of the COVID-19 outbreak on its financial condition and operations[88]. - The company has established a unified insurance procurement agreement with Evergrande Life Insurance, with an annual limit of RMB 1 billion for 2019, RMB 2 billion for 2020, and RMB 3 billion for 2021, with actual expenses for 2019 amounting to RMB 122,152,000[71]. Governance and Compliance - The company’s governance committee is responsible for reviewing compliance with legal and regulatory requirements, as well as monitoring the training and development of directors and senior management[109]. - The Audit Committee assessed the effectiveness of the internal control system and financial reporting processes[103]. - The company has established a risk management framework that includes a decision-making layer (Audit Committee) and an execution layer (business segment leadership teams) to clarify responsibilities and reporting lines for risk management[116]. - The company has implemented a continuous cycle of risk identification, control implementation, inspection, and optimization to address major risk management weaknesses[126]. Future Outlook - The company has set a future revenue guidance of 5 billion HKD for the next fiscal year, indicating a growth target of 25%[62]. - The group plans to establish the first proton center in Hainan and enhance collaboration with Brigham and Women's Hospital in the U.S. to develop a multidisciplinary approach for cancer treatment[33]. - The group aims to become the world's largest and strongest new energy vehicle group within 3-5 years, with the first model "Hengchi 1" expected to debut in 2020 and full production of the series starting in 2021[36].